Please assess the completion status of the following clinical trial:

Trial Title: A Phase II, Randomized, Cross-Over, Vehicle-Controlled, Double-Blind, Multicenter Study of the Safety, Pharmacodynamics, and Preliminary Efficacy of GHRP-1/AG in Subjects With ESRD on Hemodialysis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Subjects with ESRD who have been on HD for at least 3 months and have a urea reduction rate (URR) of at least 65%.~* Subjects who are 18 to 70 years of age.~* Subjects who have a body mass index (BMI) less than 30, albumin greater than 3.3 g/dL, and MIS of 5 to 10 (inclusive).~Exclusion Criteria:~* Subjects who have diabetes and are currently taking insulin.~* Subjects who have a history of or current significant central nervous system (CNS) disorders.~* Subjects who have active infection at baseline.~* Subjects who have active or unstable cardiac or arterial disease.~* Subjects who have uncontrolled tertiary hyperparathyroid condition.~* Subjects who have anemia.~* Subjects who have a history of hepatitis or current liver disease.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).